Stem Cell Therapy for Treatment of Epilepsy
| Autor: | Parisa Goodarzi, Hamid Reza Aghayan, Masoud Soleimani, Abbas Norouzi-Javidan, Fereshteh Mohamadi-Jahani, Sharareh Jahangiri, Seyed Hasan Emami-Razavi, Bagher Larijani, Babak Arjmand |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Acta Medica Iranica, Vol 52, Iss 9 (2014) |
| Druh dokumentu: | article |
| ISSN: | 0044-6025 1735-9694 |
| Popis: | Epilepsy as one of the most common neurological disorders affects more than 50 million people worldwide with a higher prevalence rate in low-income countries. Excessive electrical discharges in neurons following neural cell damage or loss cause recurrent seizures. One of the most common and difficult to treat types of epilepsy is temporal lobe epilepsy (TLE) which results from hippocampal sclerosis. Nowadays, similar to other diseases, epilepsy also is a candidate for treatment with different types of stem cells. Various stem cell types were used for treatment of epilepsy in basic and experimental researches. Two major roles of stem cell therapy in epilepsy are prophylaxis against chronic epilepsy and amelioration cognitive function after the occurrence of TLE. Several animal studies have supported the use of these cells for treating drug-resistant TLE. Although stem cell therapy seems like a promising approach for treatment of epilepsy in the future however, there are some serious safety and ethical concerns that are needed to be eliminated before clinical application. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|